Tatiana Aranovich (Macquarie U) et al. have posted “Who Gets to See What? Information Asymmetry and the Limits of Transparency in Australia’s Medical AI Regulation” on SSRN. Here is the abstract:
Artificial intelligence (AI) is increasingly embedded in Australian healthcare, from diagnosis to patient monitoring. These technologies promise more accessible and accurate care but introduce significant safety risks. Much of this technology is also delivered through publicly funded care, which gives its transparency a public dimension alongside its clinical safety one. Transparency is widely promoted as a response to address these risks, yet little attention has been paid to whether existing medical device regulation delivers meaningful transparency (understood here as a concept distinct from explainability) for different stakeholders. This article evaluates the Australian framework through the complementary concepts of information asymmetry and meaningful transparency. Using doctrinal analysis, it maps how information flows to three principal audiences — regulators, users, and the public including independent experts — and evaluates each pathway against three criteria: accessibility, relevance and auditability. The article finds that transparency is distributed unevenly: strong to the regulator, weaker to users, and weakest to the public. It proposes a three-pillar reform agenda targeting user-facing relevance, public auditability, and the institutional translation of regulatory information into clinical practice.
